Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v7-EN
Language English English
Date Updated 2023-10-16 2023-08-04
Drug Identification Number 02236875 02236875
Brand name PRIMENE 10% PRIMENE 10%
Common or Proper name Amino Acid Injection 10% w/v Amino Acid Injection 10% w/v
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients L-ORNITHINE DIHYDROCHLORIDE L-PROLINE GLYCINE SERINE L-ASPARTIC ACID L-ALANINE L-ARGININE GLUTAMIC ACID L-TYROSINE TAURINE TRYPTOPHAN METHIONINE L-CYSTEINE L-THREONINE HISTIDINE L-PHENYLALANINE L-ISOLEUCINE L-VALINE L-LYSINE L-LEUCINE L-ORNITHINE DIHYDROCHLORIDE L-PROLINE GLYCINE SERINE L-ASPARTIC ACID L-ALANINE L-ARGININE GLUTAMIC ACID L-TYROSINE TAURINE TRYPTOPHAN METHIONINE L-CYSTEINE L-THREONINE HISTIDINE L-PHENYLALANINE L-ISOLEUCINE L-VALINE L-LYSINE L-LEUCINE
Strength(s) 318MG 300MG 400MG 400MG 600MG 800MG 840MG 1G 45MG 60MG 200MG 240MG 189MG 370MG 380MG 420MG 670MG 760MG 1.1G 1G 318MG 300MG 400MG 400MG 600MG 800MG 840MG 1G 45MG 60MG 200MG 240MG 189MG 370MG 380MG 420MG 670MG 760MG 1.1G 1G
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 250mL 250mL
ATC code B05BA B05BA
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date 2023-04-24 2023-04-24
Actual start date 2023-04-24 2023-04-24
Estimated end date 2023-08-15 2023-08-15
Actual end date 2023-08-15
Shortage status Resolved Actual shortage
Tier 3 Status No Yes
Company comments
Health Canada comments